written on 19.06.2014

EU keeps rolling out pay-for-delay penalties with plan to fine Servier, Teva


European antitrust regulators may have been a little late to the party when it comes to pay-for-delay actions but are making up for lost time. Sources are saying they will levy fines against French drugmaker Servier and Teva Pharmaceutical Industries next month for delaying the launch of generic blood pressure meds.